A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas

Clinical Trial ID NCT02048488

PubWeight™ 15.19^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02048488

Top papers